112 related articles for article (PubMed ID: 24592886)
41. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
Seidemann K; Book M; Zimmermann M; Meyer U; Welte K; Stanulla M; Reiter A
Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
[TBL] [Abstract][Full Text] [Related]
42. 5,10-Methylenetetrahydrofolate reductase single nucleotide polymorphisms and gene-environment interaction analysis in non-syndromic cleft lip/palate.
Estandia-Ortega B; Velázquez-Aragón JA; Alcántara-Ortigoza MA; Reyna-Fabian ME; Villagómez-Martínez S; González-Del Angel A
Eur J Oral Sci; 2014 Apr; 122(2):109-13. PubMed ID: 24460828
[TBL] [Abstract][Full Text] [Related]
43. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.
Pu D; Shen Y; Wu J
Autism Res; 2013 Oct; 6(5):384-92. PubMed ID: 23653228
[TBL] [Abstract][Full Text] [Related]
44. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
Schnakenberg E; Mehles A; Cario G; Rehe K; Seidemann K; Schlegelberger B; Elsner HA; Welte KH; Schrappe M; Stanulla M
BMC Med Genet; 2005 May; 6():23. PubMed ID: 15921520
[TBL] [Abstract][Full Text] [Related]
45. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
[TBL] [Abstract][Full Text] [Related]
46. The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis.
Yao P; He X; Zhang R; Tong R; Xiao H
Hematology; 2019 Dec; 24(1):10-19. PubMed ID: 30024839
[TBL] [Abstract][Full Text] [Related]
47. C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction.
Isordia-Salas I; Trejo-Aguilar A; Valadés-Mejía MG; Santiago-Germán D; Leaños-Miranda A; Mendoza-Valdéz L; Jáuregui-Aguilar R; Borrayo-Sánchez G; Majluf-Cruz A
Arch Med Res; 2010 May; 41(4):246-50. PubMed ID: 20637366
[TBL] [Abstract][Full Text] [Related]
48. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.
Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405
[TBL] [Abstract][Full Text] [Related]
49. [The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer].
Si PR; Fang DC; Zhang H; Yang LQ; Luo YH; Liao HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):794-9. PubMed ID: 16536307
[TBL] [Abstract][Full Text] [Related]
50. Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis.
Spyridopoulou KP; Dimou NL; Hamodrakas SJ; Bagos PG
Pharmacogenet Genomics; 2012 Feb; 22(2):117-33. PubMed ID: 22143415
[TBL] [Abstract][Full Text] [Related]
51. Contribution of genetic polymorphism of methylene tetrahydrofolate reductase on the effect of methotrexate in ectopic pregnancy patients.
Deng J; Chen L; Xue H; Zeng FX; Niu PG; Shi DH
J Clin Lab Anal; 2020 Jan; 34(1):e23030. PubMed ID: 31502727
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C
Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293
[TBL] [Abstract][Full Text] [Related]
53. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
Lambrecht L; Sleurs C; Labarque V; Dhooge C; Laenen A; Sinnaeve F; Renard M; Uyttebroeck A
Pharmacogenomics; 2017 Jun; 18(8):787-795. PubMed ID: 28592186
[TBL] [Abstract][Full Text] [Related]
54. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
Shendy K; Abdelkawy K; Ali AA; Belal F; Abdelhakiem M; Magdy G; Anber N; Elbarbry F
Xenobiotica; 2024 Feb; 54(2):95-105. PubMed ID: 38381003
[TBL] [Abstract][Full Text] [Related]
55. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
[TBL] [Abstract][Full Text] [Related]
56. PHARMACOGENETIC EFFECTS OF METHOTREXATE (MTX) IN UKRAINIAN PATIENTS DEPENDING ON THE MTHFR GENOTYPES (CLINICAL CASES).
Fedota O; Roschenyuk L; Tyzhnenko T; Merenkova I; Vorontsov V
Georgian Med News; 2018 Jun; (279):111-117. PubMed ID: 30035732
[TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.
Avivi I; Zuckerman T; Krivoy N; Efrati E
Leuk Lymphoma; 2014 Mar; 55(3):565-70. PubMed ID: 23829278
[TBL] [Abstract][Full Text] [Related]
58. Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcomes in Breast Cancer Patients.
Chaturvedi P; Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
Biochem Genet; 2015 Aug; 53(7-8):211-22. PubMed ID: 26014925
[TBL] [Abstract][Full Text] [Related]
59. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination.
Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA
J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107
[TBL] [Abstract][Full Text] [Related]
60. Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population.
Stanulla M; Seidemann K; Schnakenberg E; Book M; Mehles A; Welte K; Schrappe M; Reiter A
Blood; 2005 Jan; 105(2):906-7. PubMed ID: 15632215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
